Results 31 to 40 of about 12,137,319 (407)
Microplastics, potential threat to patients with lung diseases
Air pollution is one of the major risk factors for lung disease. Microplastics are a ubiquitous environmental pollutant, both indoors and in outdoor air. Microplastics have also been found in human lung tissue and sputum.
Kuo Lu +6 more
semanticscholar +1 more source
Phenotypes of Sarcoidosis-Associated Pulmonary Hypertension—A Challenging Mystery
Sarcoidosis has been a well-recognised risk factor for pulmonary hypertension (PH) for a long time, but still, the knowledge about this concatenation is incomplete.
Aneta Kacprzak +2 more
doaj +1 more source
Recent Progress of Ferroptosis in Lung Diseases
Ferroptosis is a new form of programmed cell death due to iron-dependent excess accumulation of lipid peroxides and differs from other programmed cell deaths in morphological and biochemical characteristics.
Shang Yu +5 more
semanticscholar +1 more source
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.
BACKGROUND Preclinical data have suggested that nintedanib, an intracellular inhibitor of tyrosine kinases, inhibits processes involved in the progression of lung fibrosis.
K. Flaherty +17 more
semanticscholar +1 more source
The prevalence and burden of interstitial lung diseases in the USA
Interstitial lung diseases (ILDs) are a heterogeneous group of diseases (i.e. idiopathic interstitial pneumonias, autoimmune ILDs, environmental exposure-related ILDs, sarcoidosis) but share several common clinical and pathophysiological features [1, 2].
N. Jeganathan, Matheni Sathananthan
semanticscholar +1 more source
Objectives: Various cytokines induced by inhalation of coal dust may mediate inflammation and lead to tissue damage or fibrosis, such as coal workers' pneumoconiosis (CWP).
Jong Seong Lee +5 more
doaj +1 more source
Imaging Plays a Key Role in the Diagnosis and Control of the Treatment of Bone Sarcoidosis
Sarcoidosis is a multisystem granulomatous disease of unknown origin. The most frequent localizations are thoracic lymph nodes and/or parenchymal lung disease, nevertheless any other organ may be involved.
Katarzyna Błasińska +4 more
doaj +1 more source
Guanylyl cyclase activation reverses resistive breathing–induced lung injury and inflammation [PDF]
Inspiratory resistive breathing (RB), encountered in obstructive lung diseases, induces lung injury. The soluble guanylyl cyclase (sGC)/cyclic guanosine monophosphate (cGMP) pathway is down-regulated in chronic and acute animal models of RB, such as ...
Brouckaert, Peter +15 more
core +2 more sources
Palliative care for people with non-malignant lung disease: summary of current evidence and future direction [PDF]
Background: The physical and psychosocial needs of patients with chronic non-malignant lung disease are comparable to those with lung cancer. This article will focus on chronic obstructive pulmonary disease, interstitial lung disease and cystic fibrosis ...
Boland, Jason +5 more
core +1 more source
Intra-vesical instillations with bacillus Calmette-Guerin (BCG) are the established adjuvant therapy for superficial bladder cancer. Although generally safe and well tolerated, they may cause a range of different, local, and systemic complications.
Katarzyna Lewandowska +6 more
doaj +1 more source

